BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25519708)

  • 21. Resource use and costs associated with different states of breast cancer.
    Lidgren M; Wilking N; Jönsson B; Rehnberg C
    Int J Technol Assess Health Care; 2007; 23(2):223-31. PubMed ID: 17493308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan.
    Chen PC; Lee JC; Wang JD
    PLoS One; 2015; 10(7):e0133755. PubMed ID: 26207912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of laparoscopy in rectal cancer.
    Keller DS; Champagne BJ; Reynolds HL; Stein SL; Delaney CP
    Dis Colon Rectum; 2014 May; 57(5):564-9. PubMed ID: 24819095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?
    Hagman J
    Acta Ophthalmol; 2013 May; 91 Thesis 3():1-47. PubMed ID: 23621767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs of illness: United States, 1980.
    Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
    Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence on the cost and cost-effectiveness of palliative care: a literature review.
    Smith S; Brick A; O'Hara S; Normand C
    Palliat Med; 2014 Feb; 28(2):130-50. PubMed ID: 23838378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical expenditures of terminal cancer patients during the last year of life.
    Long SH; Gibbs JO; Crozier JP; Cooper DI; Newman JF; Larsen AM
    Inquiry; 1984; 21(4):315-27. PubMed ID: 6240463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary-care-based episodes of care and their costs in a three-month follow-up in Finland.
    Heinonen J; Koskela TH; Soini E; Ryynänen OP
    Scand J Prim Health Care; 2015; 33(4):283-90. PubMed ID: 26683288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost savings and enhanced hospice enrollment with a home-based palliative care program implemented as a hospice-private payer partnership.
    Kerr CW; Donohue KA; Tangeman JC; Serehali AM; Knodel SM; Grant PC; Luczkiewicz DL; Mylotte K; Marien MJ
    J Palliat Med; 2014 Dec; 17(12):1328-35. PubMed ID: 25375799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs for patients with psychotic illness: differences depending upon state of remission.
    Hjortsberg C; Helldin L; Hjaerthag F; Loethgren M
    J Ment Health Policy Econ; 2011 Jun; 14(2):87-93. PubMed ID: 21881164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costs associated with resource utilization during the palliative phase of care: a Canadian perspective.
    Dumont S; Jacobs P; Fassbender K; Anderson D; Turcotte V; Harel F
    Palliat Med; 2009 Dec; 23(8):708-17. PubMed ID: 19837702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for survival in colorectal cancer patients.
    Laohavinij S; Maneechavakajorn J; Techatanol P
    J Med Assoc Thai; 2010 Oct; 93(10):1156-66. PubMed ID: 20973318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs and quality of life for patients with multiple sclerosis in Belgium.
    Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The economic burden of metastatic breast cancer: a U.S. managed care perspective.
    Montero AJ; Eapen S; Gorin B; Adler P
    Breast Cancer Res Treat; 2012 Jul; 134(2):815-22. PubMed ID: 22684273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of environment and healthcare structures on the survival of patients with colorectal cancer: a French population-based study.
    Borie F; Daurès JP; Millat B; Puch P; Tretarre B
    J Surg Oncol; 2002 Jul; 80(3):137-42. PubMed ID: 12115796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.